Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial - AllTheNews.today

Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial

The interim Phase I trial data was only from 35 people, but results look good so far.
Read Full Article →
arstechnica.com
← Back to Latest